World Pharma News - Drug Injury Watch: FDA Warns Sandoz About Possible Quality-Control Problems At Its North Carolina Generic Drug Manufacturing Facility

3
Vote

Drug Injury Watch: FDA Warns Sandoz About Possible Quality-Control Problems At Its North Carolina Generic Drug Manufacturing Facility

Posted by tjlpa 100 days ago (http://www.drug-injury.com)
Category: Blogs | Tags: sandoz generic-drugs fda drug-safety

Inspection Found Sandoz Failed To Properly Validate Manufacturing Process For Metoprolol Succinate ER Tablets (Generic Form Of Toprol XL) Before Distributing Pills
Discuss Add this link to... Bury

Comments Who Voted Related Links

Comments

Who voted for this story

Related Links